eli lilly weight loss

Eli Lilly, food and drug administration

Eli Lilly plans launch of weight-loss drug in emerging markets by 2026, CFO says

(Reuters) -Eli Lilly plans to launch its blockbuster diabetes and weight-loss drug, Mounjaro, in countries like China, India, Brazil and Mexico by 2026, Chief Financial Officer Lucas Montarce said on Monday.

Devdiscourse · 1d

Eli Lilly Expands Horizons: Launching Weight-Loss Drug in Emerging Markets

Eli Lilly is set to launch its popular weight-loss drug in emerging markets, including India, Brazil, and Mexico, by mid-2025 to meet rising global demand. The strategic expansion offers a significant market opportunity due to the high prevalence of obesity in these populous countries.

The Associated Press on MSN · 5d

Danish drugmaker Novo Nordisk said Wednesday that it will drop prices 23% for all doses of Wegovy. The new monthly price of $499 takes effect immediately.

STAT · 12h

Pharmalittle: We’re reading about Lilly and Roche weight loss drugs, FDA and compounders, and more

Three U.S. senators are calling on Robert Kennedy Jr. to disclose what he and President Trump discussed with drugmakers

State of Weight Loss Drugs

BBC · 15h

Who can get weight loss drugs on the NHS in Scotland?

The medicines watchdog has agreed the drugs are safe and cost-effective for NHS use. Last year, semaglutide was approved for treating obesity under the brand name Wegovy. It has also been licensed under the brand name Ozempic for treating diabetes in some circumstances,

ABC News · 8h

Compound versions of weight loss drugs will no longer be available, FDA rules

The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until March 19 to stop, according to the FDA.

The Motley Fool on MSN · 1d

The State of Weight Loss Drugs

In this podcast, Motley Fool analyst Karl Thiel joins host Ricky Mulvey to check in on the GLP-1 landscape. They discuss: How weight loss drugs actually work, and how big-name prescriptions differ from each other.

Eli Lilly's first weight loss pill could expand access to GLP-1s around the globe, executive says

Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.

17hon MSN

Is Eli Lilly Stock a Buy?

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

STAT4h

Eli Lilly’s Dave Ricks takes home $114 million as obesity drugs fuel company’s fortunes

Eli Lilly’s rising fortunes tied to its weight loss and diabetes drugs led to a nine-figure payday for its top executive.

CNN on MSN13d

Zepbound maker Eli Lilly announces $27 billion investment in US drug manufacturing as Trump threatens tariffs

Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an ...

1don MSN

Why Eli Lilly Stock Flopped Today

Zeroing in on Eli Lilly, the company is already well established with Zepbound, which should continue to sell briskly as the world waits for a more powerful and efficacious obesity drug to hit the ...

6don MSN

Wegovy price cut: Novo Nordisk cuts the price of the weight-loss drug for the uninsured

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...

Fierce Healthcare4d

Eli Lilly expands telehealth access to low-cost Zepbound with Teladoc Health, LifeMD tie-ups

Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial ...

Amgen: Riding The MariTide Of Monthly Weight Loss

MariTide’s opportunity in diabetes should not be ignored. In addition to reducing weight by 17%, it reduced HbA1c up to 2.2% ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results